Daniela Vilasboas-Campos specializes in neurodegenerative diseases, with a particular focus on developing therapeutic approaches for Machado-Joseph Disease (MJD)/Spinocerebellar Ataxia Type 3 (SCA3). Her research emphasizes evaluating the neuroprotective potential of compounds and medicinal plant extracts, as well as elucidating the cellular mechanisms underlying their pharmacological effects. Using advanced animal models, her work aims to bridge the gap between basic research and clinical applications in the treatment of MJD/SCA3.